1
|
Szentesi A, Hegyi P, on behalf of the Hungarian Pancreatic Study Group. The 12-Year Experience of the Hungarian Pancreatic Study Group. J Clin Med 2025; 14:1362. [PMID: 40004893 PMCID: PMC11855942 DOI: 10.3390/jcm14041362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2025] [Revised: 02/11/2025] [Accepted: 02/14/2025] [Indexed: 02/27/2025] Open
Abstract
The Hungarian Pancreatic Study Group (HPSG) was established with the aim of advancing pancreatology. Our summary outlines the methodologies, key results, and future directions of the HPSG. Methodological elements included, the formation of strategic national and international collaborations, the establishment of patient registries and biobanks, and a strong focus on education and guideline development. Key results encompassed, pioneering research on pancreatic ductal function and the role of cystic fibrosis transmembrane conductance regulator (CFTR) in inflammation, significant advancements in understanding acute and chronic pancreatitis, and the execution of numerous clinical trials to explore new therapeutic approaches. Despite challenges, such as securing funding and translating research into clinical practice, the HPSG's commitment to patient care and scientific innovation has been unwavering. The group aims to deepen research into pancreatic cancer and chronic pancreatitis, conduct more randomized controlled trials (RCTs), and expand its efforts internationally by involving global staff and patients. The authors hope that this summary inspires others to undertake similar initiatives and contribute to the global advancement of medical research and patient care in pancreatology.
Collapse
Affiliation(s)
- Andrea Szentesi
- Institute for Translational Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary;
| | - Péter Hegyi
- Institute for Translational Medicine, Medical School, University of Pécs, 7624 Pécs, Hungary;
- Institute of Pancreatic Diseases, Semmelweis University, 1083 Budapest, Hungary
- Centre for Translational Medicine, Semmelweis University, 1085 Budapest, Hungary
- Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation, University of Szeged, 6720 Szeged, Hungary
| | | |
Collapse
|
2
|
Ning C, Ouyang H, Xiao J, Wu D, Sun Z, Liu B, Shen D, Hong X, Lin C, Li J, Chen L, Zhu S, Li X, Xia F, Huang G. Development and validation of an explainable machine learning model for mortality prediction among patients with infected pancreatic necrosis. EClinicalMedicine 2025; 80:103074. [PMID: 39911245 PMCID: PMC11795559 DOI: 10.1016/j.eclinm.2025.103074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2024] [Revised: 01/07/2025] [Accepted: 01/08/2025] [Indexed: 02/07/2025] Open
Abstract
Background Infected pancreatic necrosis (IPN) represents a severe complication of acute pancreatitis, commonly linked with mortality rates ranging from 15% to 35%. However, the present mortality prediction tools for IPN are limited and lack sufficient sensitivity and specificity. This study aims to develop and validate an explainable machine learning (ML) model for death prediction among patients with IPN. Methods We performed a prospective cohort study of 344 patients with IPN consecutively enrolled from a large Chinese tertiary hospital from January 2011 to January 2023. Ten ML models were developed to predict 90-day mortality in these patients. A benchmarking test, involving nested resampling, automatic hyperparameter tuning and random search techniques, was conducted to select the ML model. Sequential forward selection method was employed to select the optimal feature subset from 31 candidate subsets to simplify the model and maximize predictive performance. The final model was internally validated with the 1000 bootstrap method and externally validated using an independent cohort of 132 patients with IPN retrospectively collected from another Chinese tertiary hospital from January 2018 to January 2023. The SHapley Additive exPlanations (SHAP) method was employed to interpret the model in terms of features importance and features effect. The final model constructed with optimal feature subset was deployed as an interactive web-based Shiny app. Findings Random survival forest (RSF) model showed the best predictive performance than other 9 ML models (internal validation, C-index = 0.863 [95% CI: 0.854-0.875]; external validation, C-index = 0.857 [95% CI: 0.850-0.865]). Multiple organ failure, Acute Physiology and Chronic Health Examination II (APACHE II) score ≥20, duration of organ failure ≥21 days, bloodstream infection, time from onset to first intervention <30 days, Bedside Index of Severity in Acute Pancreatitis score ≥3, critical acute pancreatitis, age ≥ 50 years, and hemorrhage were 9 most important features associated with mortality. Furthermore, SHAP algorithm revealed insightful nonlinear interactive associations between important predictors and mortality, identifying 9 features pairs with high interaction SHAP value and clinical significance. Two interactive web-based Shiny apps were developed to enhance clinical practicability: https://rsfmodels.shinyapps.io/IPN_app/ for cases where the APACHE II score was available and https://rsfmodels.shinyapps.io/IPNeasy/ for cases where it was not. Interpretation An explainable ML model for death prediction among IPN patients was feasible and effective, suggesting its superior potential in guiding clinical management and improving patient outcomes. Two publicly accessible web tools generated for the optimized model facilitated its utility in clinical settings. Funding The Natural Science Foundation of Hunan Province (2023JJ30885), Postdoctoral Fellowship Program of CPSF (GZB20230872), The Youth Science Foundation of Xiangya Hospital (2023Q13), The Project Program of National Clinical Research Center for Geriatric Disorders of Xiangya Hospital (2021LNJJ19).
Collapse
Affiliation(s)
- Caihong Ning
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- FuRong Laboratory, Changsha, Hunan Province 410078, China
| | - Hui Ouyang
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Jie Xiao
- Department of Emergency, Third Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Di Wu
- Department of Emergency, Third Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Zefang Sun
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Baiqi Liu
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Dingcheng Shen
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Xiaoyue Hong
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Chiayan Lin
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Jiarong Li
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Lu Chen
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Shuai Zhu
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Xinying Li
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Fada Xia
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
| | - Gengwen Huang
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- Division of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China
- FuRong Laboratory, Changsha, Hunan Province 410078, China
| |
Collapse
|
3
|
Podda M, Pellino G, Di Saverio S, Coccolini F, Pacella D, Cioffi SPB, Virdis F, Balla A, Ielpo B, Pata F, Poillucci G, Ortenzi M, Damaskos D, De Simone B, Sartelli M, Leppaniemi A, Jayant K, Catena F, Giuliani A, Di Martino M, Pisanu A. Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study. Updates Surg 2023; 75:493-522. [PMID: 36899292 PMCID: PMC10005914 DOI: 10.1007/s13304-023-01488-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Accepted: 02/24/2023] [Indexed: 03/12/2023]
Abstract
The identification of high-risk patients in the early stages of infected pancreatic necrosis (IPN) is critical, because it could help the clinicians to adopt more effective management strategies. We conducted a post hoc analysis of the MANCTRA-1 international study to assess the association between clinical risk factors and mortality among adult patients with IPN. Univariable and multivariable logistic regression models were used to identify prognostic factors of mortality. We identified 247 consecutive patients with IPN hospitalised between January 2019 and December 2020. History of uncontrolled arterial hypertension (p = 0.032; 95% CI 1.135-15.882; aOR 4.245), qSOFA (p = 0.005; 95% CI 1.359-5.879; aOR 2.828), renal failure (p = 0.022; 95% CI 1.138-5.442; aOR 2.489), and haemodynamic failure (p = 0.018; 95% CI 1.184-5.978; aOR 2.661), were identified as independent predictors of mortality in IPN patients. Cholangitis (p = 0.003; 95% CI 1.598-9.930; aOR 3.983), abdominal compartment syndrome (p = 0.032; 95% CI 1.090-6.967; aOR 2.735), and gastrointestinal/intra-abdominal bleeding (p = 0.009; 95% CI 1.286-5.712; aOR 2.710) were independently associated with the risk of mortality. Upfront open surgical necrosectomy was strongly associated with the risk of mortality (p < 0.001; 95% CI 1.912-7.442; aOR 3.772), whereas endoscopic drainage of pancreatic necrosis (p = 0.018; 95% CI 0.138-0.834; aOR 0.339) and enteral nutrition (p = 0.003; 95% CI 0.143-0.716; aOR 0.320) were found as protective factors. Organ failure, acute cholangitis, and upfront open surgical necrosectomy were the most significant predictors of mortality. Our study confirmed that, even in a subgroup of particularly ill patients such as those with IPN, upfront open surgery should be avoided as much as possible. Study protocol registered in ClinicalTrials.Gov (I.D. Number NCT04747990).
Collapse
Affiliation(s)
- Mauro Podda
- Emergency Surgery Unit, Department of Surgical Science, Policlinico Universitario "D. Casula", Azienda Ospedaliero-Universitaria di Cagliari, University of Cagliari, SS 554, Km 4,500, Monserrato, 09042, Cagliari, Italy.
| | - Gianluca Pellino
- Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
- Colorectal Surgery Unit, Vall d'Hebron University Hospital, Barcelona, Spain
| | - Salomone Di Saverio
- Department of Surgery, "Madonna del Soccorso" Hospital, San Benedetto del Tronto, Italy
| | - Federico Coccolini
- General, Emergency and Trauma Surgery Unit, Pisa University Hospital, Pisa, Italy
| | - Daniela Pacella
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | | | - Francesco Virdis
- Trauma and Acute Care Surgery Unit, "Niguarda Ca Granda" Hospital, Milan, Italy
| | - Andrea Balla
- General and Minimally-Invasive Surgery Unit, "San Paolo" Hospital, Civitavecchia, Rome, Italy
| | | | - Francesco Pata
- General Surgery Unit, "Nicola Giannettasio" Hospital, Corigliano-Rossano, Italy
| | - Gaetano Poillucci
- Department of General Surgery, Policlinico Umberto I, La Sapienza University of Rome, Rome, Italy
| | - Monica Ortenzi
- Department of General and Emergency Surgery, Marche Polytechnic University, Ancona, Italy
| | - Dimitrios Damaskos
- Department of Upper G.I. Surgery, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
| | - Belinda De Simone
- Department of Emergency and Metabolic Minimally Invasive Surgery, Centre Hospitalier Intercommunal de Poissy/Saint Germain en Laye, Poissy Cedex, France
| | | | - Ari Leppaniemi
- Department of Abdominal Surgery, Abdominal Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Kumar Jayant
- Department of Surgery & Cancer, Imperial College London, Du Cane Road, London, UK
| | - Fausto Catena
- Department of Emergency and Trauma Surgery, "Bufalini" Hospital, Cesena, Italy
| | - Antonio Giuliani
- General and Emergency Surgery Unit, San Carlo Hospital, Potenza, Italy
| | - Marcello Di Martino
- Division of Hepatobiliary and Liver Transplantation Surgery, "A.O.R.N. Cardarelli", Naples, Italy
| | - Adolfo Pisanu
- Emergency Surgery Unit, Department of Surgical Science, Policlinico Universitario "D. Casula", Azienda Ospedaliero-Universitaria di Cagliari, University of Cagliari, SS 554, Km 4,500, Monserrato, 09042, Cagliari, Italy
| |
Collapse
|
4
|
Huang H, Peng J, Ning C, Wei Q, Li J, Lin C, Sun Z, Chen L, Zhu S, Shen D, Huang G. Escherichia coli infection indicates favorable outcomes in patients with infected pancreatic necrosis. Front Cell Infect Microbiol 2023; 13:1107326. [PMID: 37051298 PMCID: PMC10083358 DOI: 10.3389/fcimb.2023.1107326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Accepted: 03/14/2023] [Indexed: 03/28/2023] Open
Abstract
IntroductionInfected pancreatic necrosis (IPN) is a severe complication of acute necrotizing pancreatitis with increasing morbidity. Escherichia coli is the most frequently cultured microorganism in IPN. However, the implications of Escherichia coli infection on the outcomes of patients with IPN remain unclear. Therefore, this study aimed to evaluate the clinical impacts of Escherichia coli infection on IPN.MethodsA prospective database with consecutive patients with IPN between January 2010 and April 2022 at a tertiary hospital was post-hoc analyzed. The clinical and microbiological characteristics, surgical management, and follow-up data of patients with and without Escherichia coli infection were compared.ResultsA total of 294 IPN patients were enrolled in this cohort. Compared with non-Escherichia coli infection cases (n=80, 27.2%), patients with Escherichia coli infection (n=214, 72.8%) were characterized by more frequent polymicrobial infections (77.5% vs. 65.0%, P=0.04) but a lower occurrence of severe acute pancreatitis (SAP) (42.5% vs. 61.7%, P=0.003). In addition, significantly lower mortality (12.5% vs. 30.4%, p=0.002), fewer step-up surgical interventions (73.8% vs. 85.1%, P=0.025), and a lower rate of multiple organ failure (MOF) (25.0% vs. 40.2%, P=0.016) were also observed in patients with Escherichia coli infection. Multivariate analysis of mortality predictors indicated that MOF (odds ratio [OR], 6.197; 95% confidence interval [CI], 2.373–16.187; P<0.001) and hemorrhage (OR, 3.485; 95% CI, 1.623–7.487; P=0.001) were independent predictors associated with higher mortality in patients with IPN. Escherichia coli infection was significantly associated with a lower mortality (OR, 0.302; 95% CI, 0.121–0.751; P= 0.01).ConclusionEscherichia coli infection indicates a favorable prognosis in patients with IPN, although the mechanism needs further investigation.
Collapse
Affiliation(s)
- Haosu Huang
- Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
| | - Jie Peng
- Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
| | - Caihong Ning
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Qin Wei
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Jiarong Li
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Chiayen Lin
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Zefang Sun
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Lu Chen
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Shuai Zhu
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Dingcheng Shen
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- *Correspondence: Gengwen Huang, ; Dingcheng Shen,
| | - Gengwen Huang
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- Department of Pancreatic Surgery, General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- Department of Hernia and Abdominal Wall Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
- *Correspondence: Gengwen Huang, ; Dingcheng Shen,
| |
Collapse
|
5
|
Ni T, Wen Y, Zhao B, Ning N, Chen E, Mao E, Zhou W. Characteristics and risk factors for extrapancreatic infection in patients with moderate or severe acute pancreatitis. Heliyon 2023; 9:e13131. [PMID: 36755607 PMCID: PMC9900262 DOI: 10.1016/j.heliyon.2023.e13131] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 01/09/2023] [Accepted: 01/18/2023] [Indexed: 01/21/2023] Open
Abstract
BACKGROUND How to detect acute pancreatitis (AP) complicated with infection early and how to arrange the treatment time are still the main problems in the world. There are few reports on the potential relationship between extrapancreatic infections and AP. The purpose of this article was to investigate the characteristics, influencing factors and prognosis of extrapancreatic infection in AP patients with modified Marshall score ≥2 on admission. MATERIALS AND METHODS We retrospectively analyzed AP admitted to emergency intensive care unit of Ruijin hospital within 72 h of onset from September 2019 to December 2021. In addition to the patients' baseline data, sites of infection and microorganisms outside the pancreas were collected. Microbial cultures were used to identify infections of the respiratory tract, blood, abdominal cavity, biliary tract, urinary tract and clostridium difficile in feces. RESULTS 144 patients with AP were included, of which extrapancreatic infection accounted for 40.28%. C-reactive protein, procalcitonin, blood urea nitrogen, serum creatinine, oxygenation index, modified Marshall score, BISAP score and APACHE II score were significantly increased in the extrapancreatic infection group. The risk factors of extrapancreatic infection included blood urea nitrogen, Modified Marshall score and duration of mechanical ventilation. The positive rates of pathogenic bacteria in sputum culture, blood culture, ascites culture and bile culture were significantly higher than those in the 1-3 days after admission. The infection begins to worsen as early as 4-7 days after the onset of symptoms. Extrapancreatic infection is associated with pancreatic necrosis, the rate of laparotomy, length of hospital stay and in-hospital mortality. CONCLUSION Our research has confirmed the need to prevent and monitor extrapancreatic infection in the early stage.
Collapse
Affiliation(s)
- Tongtian Ni
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Yi Wen
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Bing Zhao
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ning Ning
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Erzhen Chen
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Enqiang Mao
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Weijun Zhou
- Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
6
|
Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Acute Pancreatitis: Diagnosis and Treatment. Drugs 2022; 82:1251-1276. [PMID: 36074322 PMCID: PMC9454414 DOI: 10.1007/s40265-022-01766-4] [Citation(s) in RCA: 228] [Impact Index Per Article: 76.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/04/2022] [Indexed: 11/11/2022]
Abstract
Acute pancreatitis is a common indication for hospital admission, increasing in incidence, including in children, pregnancy and the elderly. Moderately severe acute pancreatitis with fluid and/or necrotic collections causes substantial morbidity, and severe disease with persistent organ failure causes significant mortality. The diagnosis requires two of upper abdominal pain, amylase/lipase ≥ 3 ×upper limit of normal, and/or cross-sectional imaging findings. Gallstones and ethanol predominate while hypertriglyceridaemia and drugs are notable among many causes. Serum triglycerides, full blood count, renal and liver function tests, glucose, calcium, transabdominal ultrasound, and chest imaging are indicated, with abdominal cross-sectional imaging if there is diagnostic uncertainty. Subsequent imaging is undertaken to detect complications, for example, if C-reactive protein exceeds 150 mg/L, or rarer aetiologies. Pancreatic intracellular calcium overload, mitochondrial impairment, and inflammatory responses are critical in pathogenesis, targeted in current treatment trials, which are crucially important as there is no internationally licenced drug to treat acute pancreatitis and prevent complications. Initial priorities are intravenous fluid resuscitation, analgesia, and enteral nutrition, and when necessary, critical care and organ support, parenteral nutrition, antibiotics, pancreatic exocrine and endocrine replacement therapy; all may have adverse effects. Patients with local complications should be referred to specialist tertiary centres to guide further management, which may include drainage and/or necrosectomy. The impact of acute pancreatitis can be devastating, so prevention or reduction of the risk of recurrence and progression to chronic pancreatitis with an increased risk of pancreas cancer requires proactive management that should be long term for some patients.
Collapse
Affiliation(s)
- Peter Szatmary
- Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - Tassos Grammatikopoulos
- Paediatric Liver, GI and Nutrition Centre, King's College Hospital NHS Foundation Trust, London, UK
| | - Wenhao Cai
- Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,West China Centre of Excellence for Pancreatitis and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China
| | - Wei Huang
- West China Centre of Excellence for Pancreatitis and West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, China
| | - Rajarshi Mukherjee
- Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.,Department of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool , UK
| | - Chris Halloran
- Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.,Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
| | - Georg Beyer
- Department of Medicine II, University Hospital, LMU Munich, Munich, Germany
| | - Robert Sutton
- Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. .,Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. .,Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
| |
Collapse
|
7
|
Kui B, Pintér J, Molontay R, Nagy M, Farkas N, Gede N, Vincze Á, Bajor J, Gódi S, Czimmer J, Szabó I, Illés A, Sarlós P, Hágendorn R, Pár G, Papp M, Vitális Z, Kovács G, Fehér E, Földi I, Izbéki F, Gajdán L, Fejes R, Németh BC, Török I, Farkas H, Mickevicius A, Sallinen V, Galeev S, Ramírez‐Maldonado E, Párniczky A, Erőss B, Hegyi PJ, Márta K, Váncsa S, Sutton R, Szatmary P, Latawiec D, Halloran C, de‐Madaria E, Pando E, Alberti P, Gómez‐Jurado MJ, Tantau A, Szentesi A, Hegyi P, the Hungarian Pancreatic Study Group. EASY-APP: An artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis. Clin Transl Med 2022; 12:e842. [PMID: 35653504 PMCID: PMC9162438 DOI: 10.1002/ctm2.842] [Citation(s) in RCA: 49] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 04/06/2022] [Accepted: 04/11/2022] [Indexed: 12/17/2022] Open
Abstract
BACKGROUND Acute pancreatitis (AP) is a potentially severe or even fatal inflammation of the pancreas. Early identification of patients at high risk for developing a severe course of the disease is crucial for preventing organ failure and death. Most of the former predictive scores require many parameters or at least 24 h to predict the severity; therefore, the early therapeutic window is often missed. METHODS The early achievable severity index (EASY) is a multicentre, multinational, prospective and observational study (ISRCTN10525246). The predictions were made using machine learning models. We used the scikit-learn, xgboost and catboost Python packages for modelling. We evaluated our models using fourfold cross-validation, and the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUC), and accuracy metrics were calculated on the union of the test sets of the cross-validation. The most critical factors and their contribution to the prediction were identified using a modern tool of explainable artificial intelligence called SHapley Additive exPlanations (SHAP). RESULTS The prediction model was based on an international cohort of 1184 patients and a validation cohort of 3543 patients. The best performing model was an XGBoost classifier with an average AUC score of 0.81 ± 0.033 and an accuracy of 89.1%, and the model improved with experience. The six most influential features were the respiratory rate, body temperature, abdominal muscular reflex, gender, age and glucose level. Using the XGBoost machine learning algorithm for prediction, the SHAP values for the explanation and the bootstrapping method to estimate confidence, we developed a free and easy-to-use web application in the Streamlit Python-based framework (http://easy-app.org/). CONCLUSIONS The EASY prediction score is a practical tool for identifying patients at high risk for severe AP within hours of hospital admission. The web application is available for clinicians and contributes to the improvement of the model.
Collapse
Affiliation(s)
- Balázs Kui
- Department of MedicineUniversity of SzegedSzegedHungary
- Centre for Translational Medicine, Department of MedicineUniversity of SzegedSzegedHungary
| | - József Pintér
- Department of Stochastics, Institute of MathematicsBudapest University of Technology and EconomicsBudapestHungary
| | - Roland Molontay
- Department of Stochastics, Institute of MathematicsBudapest University of Technology and EconomicsBudapestHungary
- MTA‐BME Stochastics Research GroupBudapestHungary
| | - Marcell Nagy
- Department of Stochastics, Institute of MathematicsBudapest University of Technology and EconomicsBudapestHungary
| | - Nelli Farkas
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Institute of Bioanalysis, Medical SchoolUniversity of PécsPécsHungary
| | - Noémi Gede
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
| | - Áron Vincze
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Judit Bajor
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Szilárd Gódi
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - József Czimmer
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Imre Szabó
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Anita Illés
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Patrícia Sarlós
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Roland Hágendorn
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Gabriella Pár
- Division of Gastroenterology, First Department of MedicineUniversity of Pécs, Medical SchoolPécsHungary
| | - Mária Papp
- Department of Gastroenterology, Institute of Internal Medicine, Faculty of MedicineUniversity of DebrecenDebrecenHungary
| | - Zsuzsanna Vitális
- Department of Gastroenterology, Institute of Internal Medicine, Faculty of MedicineUniversity of DebrecenDebrecenHungary
| | - György Kovács
- Department of Gastroenterology, Institute of Internal Medicine, Faculty of MedicineUniversity of DebrecenDebrecenHungary
| | - Eszter Fehér
- Department of Gastroenterology, Institute of Internal Medicine, Faculty of MedicineUniversity of DebrecenDebrecenHungary
| | - Ildikó Földi
- Department of Gastroenterology, Institute of Internal Medicine, Faculty of MedicineUniversity of DebrecenDebrecenHungary
| | - Ferenc Izbéki
- Szent György Teaching Hospital of County FejérSzékesfehérvárHungary
| | - László Gajdán
- Szent György Teaching Hospital of County FejérSzékesfehérvárHungary
| | - Roland Fejes
- Szent György Teaching Hospital of County FejérSzékesfehérvárHungary
| | - Balázs Csaba Németh
- Department of MedicineUniversity of SzegedSzegedHungary
- Centre for Translational Medicine, Department of MedicineUniversity of SzegedSzegedHungary
| | - Imola Török
- County Emergency Clinical Hospital of Târgu Mures—Gastroenterology Clinic and University of Medicine, Pharmacy, Sciences and Technology ‘George Emil Palade’Targu MuresRomania
| | - Hunor Farkas
- County Emergency Clinical Hospital of Târgu Mures—Gastroenterology Clinic and University of Medicine, Pharmacy, Sciences and Technology ‘George Emil Palade’Targu MuresRomania
| | | | - Ville Sallinen
- Department of Transplantation and Liver SurgeryHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | | | | | - Andrea Párniczky
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Heim Pál National Pediatric InstituteBudapestHungary
| | - Bálint Erőss
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Division of Pancreatic Diseases, Heart and Vascular CentreSemmelweis UniversityBudapestHungary
- Centre for Translational MedicineSemmelweis UniversityBudapestHungary
| | - Péter Jenő Hegyi
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Division of Pancreatic Diseases, Heart and Vascular CentreSemmelweis UniversityBudapestHungary
| | - Katalin Márta
- Division of Pancreatic Diseases, Heart and Vascular CentreSemmelweis UniversityBudapestHungary
- Centre for Translational MedicineSemmelweis UniversityBudapestHungary
| | - Szilárd Váncsa
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Division of Pancreatic Diseases, Heart and Vascular CentreSemmelweis UniversityBudapestHungary
- Centre for Translational MedicineSemmelweis UniversityBudapestHungary
| | - Robert Sutton
- Institute of Systems, Molecular and Integrative BiologyUniversity of Liverpool and Liverpool University Hospitals NHS Foundation Trust, Liverpool, EnglandUK
| | - Peter Szatmary
- Institute of Systems, Molecular and Integrative BiologyUniversity of Liverpool and Liverpool University Hospitals NHS Foundation Trust, Liverpool, EnglandUK
| | - Diane Latawiec
- Institute of Systems, Molecular and Integrative BiologyUniversity of Liverpool and Liverpool University Hospitals NHS Foundation Trust, Liverpool, EnglandUK
| | - Chris Halloran
- Institute of Systems, Molecular and Integrative BiologyUniversity of Liverpool and Liverpool University Hospitals NHS Foundation Trust, Liverpool, EnglandUK
| | - Enrique de‐Madaria
- Gastroenterology DepartmentAlicante University General HospitalISABIALAlicanteSpain
| | - Elizabeth Pando
- Department of Hepato‐Pancreato‐Biliary and Transplant SurgeryHospital Universitari Vall d'Hebron, Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Piero Alberti
- Department of Hepato‐Pancreato‐Biliary and Transplant SurgeryHospital Universitari Vall d'Hebron, Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Maria José Gómez‐Jurado
- Department of Hepato‐Pancreato‐Biliary and Transplant SurgeryHospital Universitari Vall d'Hebron, Universitat Autònoma de BarcelonaBarcelonaSpain
| | - Alina Tantau
- The 4th Medical ClinicIuliu Hatieganu’ University of Medicine and PharmacyCluj‐NapocaRomania
- Gastroenterology and Hepatology Medical CenterCluj‐NapocaRomania
| | - Andrea Szentesi
- Centre for Translational Medicine, Department of MedicineUniversity of SzegedSzegedHungary
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
| | - Péter Hegyi
- Institute for Translational Medicine, Szentágothai Research Centre, Medical SchoolUniversity of PécsPécsHungary
- Division of Pancreatic Diseases, Heart and Vascular CentreSemmelweis UniversityBudapestHungary
- Centre for Translational MedicineSemmelweis UniversityBudapestHungary
| | | |
Collapse
|